A BIO-MEDICAL company which has pioneered a technology to speed up the diagnosis of cervical cancer is moving out of Yorkshire after raising nearly £1m to fund investment.

Zilico, which was originally spun out from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, will be headquartered in Manchester after securing £750,000 from the The North West Fund for Biomedical and raising a further £235,000 from new and existing investors, including Fusion IP plc.

Zilico is dev......for the full story register now for free or login below...